NL-BPC-157

NL-BPC-157 – the world’s first supplement containing NL-BPC-157 synthesised using our new patented NL-PEPTIDES TM technology, known as novel peptides.

The new NL-BPC-157 TM form of the peptide that we have developed is significantly different from the usual form of the peptide and is much more effective than the ARG-BPC-157 form.

• • The next-generation peptide NL- BPC-157 TM is resistant to high temperature and low pH.

• • Thanks to our patent-protected NL-PEPTIDES-DELIVERY TM technology, the peptide is absorbed from its position in the small intestine through the use of protease inhibitors and absorption enhancers, such as: L-carnitine and citric acid.

• • The product contains a pharmaceutical composition that is stable and storable under various conditions. By separating the enzyme inhibitor from the peptide, the inhibitor will not degrade the peptide in the capsule.

• • Thanks to the use of a new generation of NL-PEPTIDES TM peptides, non-degradable in the small intestine while releasing an enzyme inhibitor, the product components are not mutually exclusive at any stage during this method of delivery. NL-PEPTIDES peptides are resistant to degrading agents that can occur in the gut. This allows them to be absorbed in their entirety.

Composition
Pack size: 30 capsules
Single serving: 1 capsule